Need Help?

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

WES and clonality characterization of different timepoints in HER2-negative primary breast cancers receiving neoadjuvant eribulin therapy.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001006980 Illumina HiSeq 2500 94